Back to portfolio

Terray Therapeutics, Inc.

Novel screening and optimization platform (tArray) to develop treatments for historically intractable causes of human disease

Terray Therapeautics was founded in 2018 by brothers Jacob and Eli Berlin and joined by Greg Copeland. The company is developing an AI-powered drug discovery platform using a novel spatially encoded screening and optimization application (tArray) to develop treatments, enabling users to advance their drug candidates.